- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr W. Clay Jackson: Clinician Burnout Impacts Both Personal and Patient Outcomes
W. Clay Jackson, MD, DipTh, clinical assistant professor of psychiatry, department of family medicine, University of Tennessee College of Medicine, discusses how clinician burnout impacts not only personal outcomes, but also patient outcomes.
W. Clay Jackson, MD, DipTh, clinical assistant professor of psychiatry, department of family medicine, University of Tennessee College of Medicine, discusses how clinician burnout impacts not only personal outcomes, but also patient outcomes.
TranscriptHow does clinician burnout impact not only personal outcomes, but also patient outcomes?
We’re really discovering that clinicians who are not well don’t do well. They don’t do well for themselves, families, communities, but they also don’t do well for patients. There have been some recent self-reports of suboptimal care that give us grave concern regarding the effects of burnout on both medical performance and surgical performance.
There was a study of approximately 8000 surgeons that was retrospective. They looked at the last 90 days and said have you had a major medical error? And in all 3 areas of burnout, we found that surgeons who experience these areas of burnout were much more likely than their colleagues to report a major medical error. There’ also a study of internal medicine residents, and during residency training, there’s a great risk of burnout because clinicians are increasing in terms of their complexity of task they’re asked to perform and they’re at the lower end of the training scale, in terms of experience.
Internal medicine residents were 3 times as likely to report medical errors if they had burnout than if they did not.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More
